| Line Item | 2023-11-30 | Y/Y |
|---|---|---|
| Revenue | $77.0M | +99.3% |
| R&D Expense | $189.1M | +2.5% |
| SG&A Expense | $42.9M | +12.9% |
| Operating Income | -$155.1M | +15.7% |
| Pre-tax Income | -$143.9M | +20.2% |
| Net Income | -$143.9M | +20.2% |
| EPS (Basic) | -$2.65 | +28.6% |
| EPS (Diluted) | -$2.65 | +28.6% |
| Line Item | 2023-11-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.6M | -15.3% |
| Current Assets | $295.5M | -7.2% |
| Total Assets | $355.6M | -14.7% |
| Current Liabilities | $87.0M | +23.1% |
| Total Liabilities | $155.1M | +37.2% |
| Stockholders' Equity | $200.5M | -34.0% |
| Line Item | 2023-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.4M | +49.1% |
| Capital Expenditures | $8.4M | -31.4% |
| Investing Cash Flow | $68.3M | +151.1% |
| Financing Cash Flow | $3.2M | -97.3% |
| Free Cash Flow | -$89.8M | +47.8% |